Development of an International Prostate Cancer Outcomes Registry

被引:35
|
作者
Evans, Sue M. [1 ]
Nag, Nupur [1 ]
Roder, David [2 ]
Brooks, Andrew [3 ]
Millar, Jeremy L. [4 ]
Moretti, Kim L. [2 ]
Pryor, David [5 ]
Skala, Marketa [6 ]
McNeil, John J. [1 ]
机构
[1] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Univ S Australia, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia
[3] Westmead Hosp, Dept Urol, Westmead, NSW 2145, Australia
[4] Alfred Hlth Radiat Oncol, Melbourne, Vic, Australia
[5] Princess Alexandra Hosp, Dept Radiat Oncol, Woolloongabba, Qld, Australia
[6] WP Holman Clin, Launceston, Tas, Australia
关键词
prostate cancer; clinical registry; population health; URBAN-RURAL DIFFERENCES; MEN; CARE; PATTERNS; QUALITY; SCALE; QUEENSLAND; VALIDATION; AUSTRALIA; MORTALITY;
D O I
10.1111/bju.13258
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner. Materials and Methods Stakeholders were recruited based on their interest, importance in achieving the monitoring and reporting of clinical practice and patient outcomes, and in amalgamation of existing registries. Each participating jurisdiction is responsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through a hospital or pathology report, or from a cancer registry. Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO 27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes, and patient reported quality of life, are collected. Results Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection, to enable analysis of key quality indicators that will aid in assessing clinical practice and patient focused outcomes. Conclusion PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 50 条
  • [31] The Indonesian Situation of Prostate Cancer Registry
    Hakim, Lukman
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 97 - 97
  • [32] Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
    Chowdhury, Simon
    Bjartell, Anders
    Lumen, Nicolaas
    Maroto, Pablo
    Paiss, Thomas
    Gomez-Veiga, Francisco
    Birtle, Alison
    Kramer, Gero
    Kalinka, Ewa
    Spaeth, Dominique
    Feyerabend, Susan
    Matveev, Vsevolod
    Lefresne, Florence
    Lukac, Martin
    Wapenaarls, Robert
    Costa, Luis
    TARGETED ONCOLOGY, 2020, 15 (03) : 301 - 315
  • [33] Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry
    Simon Chowdhury
    Anders Bjartell
    Nicolaas Lumen
    Pablo Maroto
    Thomas Paiss
    Francisco Gomez-Veiga
    Alison Birtle
    Gero Kramer
    Ewa Kalinka
    Dominique Spaëth
    Susan Feyerabend
    Vsevolod Matveev
    Florence Lefresne
    Martin Lukac
    Robert Wapenaar
    Luis Costa
    Targeted Oncology, 2020, 15 : 301 - 315
  • [34] Treatment outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) and cardiovascular disorders or diabetes: The Prostate Cancer Registry.
    Lumen, Nicolaas
    Chowdhury, Simon
    Birtle, Alison J.
    Bjartell, Anders
    Costa, Luis
    Feyerabend, Susan
    Galli, Luca
    Kalinka-Warzocha, Ewa
    Kramer, Gero
    Maroto, Pablo
    Matveev, Vsevolod B.
    Paiss, Thomas
    Pisconti, Salvatore
    Spaeth, Dominique
    Veiga, Francisco Gomez
    Antoni, Laurent
    Klumper, Edwin
    Wapenaar, Robert
    Thoret-Bauchet, Florence
    Lee, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] OUTCOMES FROM AN INTERNATIONAL MULTICENTRE HEMOSPRAY REGISTRY
    Alzoubaidi, Durayd
    Rusu, Radu
    Dunn, Jason
    Rey, Johannes W.
    Gulati, Shraddha
    Hayee, Bu'Hussain
    Dixon, Selena
    Moreea, Sulleman
    Napier, Duncan
    Anderson, John
    Dahan, Martin
    Hu, Max
    Duarte, Patricia
    Boger, Phil
    Murino, Alberto
    Jameie-Oskooei, Sina
    Despott, Edward
    Steinheber, Cora
    Goetz, Martin
    Subramaniam, Sharmila
    Bhandari, Pradeep
    Lovat, Laurence
    Coron, Emmanuel
    Kiesslich, Ralf
    Haidry, Rehan
    GUT, 2018, 67 : A15 - A16
  • [36] National Radiation Oncology Registry: The pilot prostate cancer registry
    Efstathiou, Jason Alexander
    Nassif, Deborah
    Chen, Ronald C.
    Hoffman, Karen Elizabeth
    Kuban, Deborah A.
    Lawton, Colleen Anne
    Michalski, Jeff M.
    Potters, Louis
    Rose, Christopher M.
    Sandler, Howard Mark
    Suh, Warren
    Wall, Terry
    Zietman, Anthony L.
    Bekelman, Justin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [37] The Prostate Cancer Registry: First results from an international, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)
    Chowdhury, S.
    Birtle, A. J.
    Bjartell, A.
    Costa, L.
    Feyerabend, S.
    Galli, L.
    Lumen, N.
    Kalinka-Warzocha, E.
    Maroto, P.
    Matveev, V. B.
    Paiss, T.
    Spaeth, D.
    Klumper, E.
    Thingstad, T.
    Wapenaar, R.
    Lee, E.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S492 - S492
  • [38] Results of hospital cancer registry surveys by the American College of Surgeons - Outcomes of prostate cancer treatment by radical prostatectomy
    Mettlin, CJ
    Murphy, GP
    Sylvester, J
    McKee, RF
    Morrow, M
    Winchester, DP
    CANCER, 1997, 80 (09) : 1875 - 1881
  • [39] Quality of prostate cancer data in the cancer registry of Norway
    Harvei, S
    Tretli, S
    Langmark, F
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (01) : 104 - 110
  • [40] Impact of prebiopsy mri on prostate cancer staging in the norwegian prostate cancer registry
    Haug, E. S.
    Myklebust, T. A.
    Julibo-Jones, P.
    Reisaeter, L.
    Aas, K.
    Berg, A.
    Mueller, C.
    Hofmann, B.
    Storkersen, O.
    Nilsen, K. L.
    Johannesen, T. B.
    Beisland, C.
    EUROPEAN UROLOGY, 2023, 83 : S138 - S139